[EN] DISUBSTITUTED IMIDAZOLE DERIVATIVES AS MODULATORS OF RAF KINASE<br/>[FR] DÉRIVÉS D'IMIDAZOLE DISUBSTITUÉS EN TANT QUE MODULATEURS DE LA PROTÉINE KINASE RAF
申请人:NOVARTIS AG
公开号:WO2010100127A1
公开(公告)日:2010-09-10
Novel substituted imidazole compounds, compositions containing them, and methods of using them for the inhibition of Raf kinase activity are provided. The new compounds and compositions may be used either alone or in combination with an additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
提供了新型替代咪唑化合物,含有这些化合物的组合物,以及使用它们抑制Raf激酶活性的方法。这些新化合物和组合物可以单独使用,也可以与其他药物联合用于治疗由Raf激酶介导的疾病,如癌症。